Springer Nature and OpenEvidence have announced a subscription agreement that will make Springer Nature’s peer-reviewed scientific and medical content available through the OpenEvidence clinical decision support platform. Effective from August 4, the agreement is intended to provide physicians and other healthcare professionals with direct access to trusted research during patient care while ensuring that original authors receive appropriate attribution.
The collaboration forms part of Springer Nature’s community-led ARC3 licensing framework, which is designed to support the responsible use of published research in artificial intelligence applications. Under the framework, clinicians using OpenEvidence will be able to retrieve and cite content from Springer Nature publications while maintaining clear links back to the original research.
The partners said the agreement is intended to improve access to evidence at the point of care by integrating trusted scientific literature into a platform already used by healthcare professionals for clinical decision support. In addition to increasing the visibility of published research, the arrangement is expected to provide greater transparency regarding how research content is accessed and used within AI-powered tools.
“Springer Nature and OpenEvidence share a common goal – to achieve maximum exposure for scientific research, while ensuring authors receive clear attribution and that their work is connected back to its original source,” said Frank Vranken Peeters, Chief Executive Officer at Springer Nature. “By partnering with OpenEvidence, one of the leading services delivering clinical findings at the point of care for healthcare professionals, we can help clinicians access trusted research, therefore supporting better-informed decisions and greater real-world impact.”
Daniel Nadler, Chief Executive Officer and Founder of OpenEvidence, said: “Springer Nature publishes many of the world’s most influential medical journals, books, and society publications. Bringing clinical findings from the Springer Nature portfolio into OpenEvidence widens the range of questions a physician can get a deeper sourced answer to, across every major area of medicine. And, in the process, connects the authors of practice-changing medicine and research with the clinicians who use it.”
According to Springer Nature, the ARC3 framework supports three core principles: clear attribution to original research, transparency around AI usage of research content, and alignment with the publisher’s Responsible AI Principles.
Click here for the original news story.
